3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
106
Neoplasms
14
Neoplasm Metastasis
14
Carcinoma, Non-Small-Cell Lung
4
Advanced Breast Cancer
4
Hereditary Sensory and Autonomic Neuropathies
3
Recurrence
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Endometrial Neoplasms
2
Breast Neoplasms, Male
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Malignancies
1
Recurrent Uterine Corpus Carcinoma
1
Neoplasms by Site
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Lethal Congenital Contracture Syndrome 2
1
Hyperglycemia
1
Hormone Receptor Positive HER-2 Negative Breast Cancer
1
Hormone Receptor Positive Breast Cancer
1
HER2-positive Breast Cancer
1
Female Breast Carcinoma
1
Exanthema
1
Interventions
Radiotherapy
22
Fluorouracil
20
Oxaliplatin
19
Leucovorin
14
Cisplatin
14
Paclitaxel
10
Radiation
8
Irinotecan
8
Docetaxel
7
Capecitabine
7
Cetuximab
6
Carboplatin
6
pembrolizumab
5
Neoadjuvant Therapy
5
Trastuzumab
4
Taxes
4
Chemotherapy, Adjuvant
4
Panitumumab
3
Microarray Analysis
3
Immunohistochemistry
3
Folfox protocol
3
Epirubicin
3
Biopsy
3
tucatinib
2
Surgical Procedures, Operative
2
Reverse Transcriptase Polymerase Chain Reaction
2
Magnetic Resonance Spectroscopy
2
Gene Expression Profiling
2
Gefitinib
2
Everolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma Of Esophagus
×
Fulvestrant
×
Clear all
No trials found.